OIA Response: Benzathine penicillin G supply shortage
Request for information dated 28 November 2018 on the supply of benzathine penicillin G.
OIA Response: Oxycodone and opioid use
Request dated 29 March 2019 for information relating to oxycodone and the use of opioids.
OIA Response: MSTAC Minutes
Request dated 2 May 2019 for the minutes of the MSTAC meetings.
OIA Response: Mesalazine data
Request dated 14 May 2019 for information relating to mesalazine.
Proposal to list products in the surgical suction, chest and wound drainage products category supplied by Teleflex Medical New Zealand
PHARMAC is seeking feedback on a proposal to list a range of surgical suction, chest and wound drainage products in Part III of Section H of the Pharmaceutical Schedule from 1 September 2019 through a provisional Agreement with Teleflex Medical New Zealand.
Closes: 4pm Tuesday, 16 July 2019.
Proposal to list medical devices supplied by ResMed NZ Limited
PHARMAC is seeking feedback on a proposal to list a range of non-invasive ventilation products in Part III of Section H of the Pharmaceutical Schedule from 1 September 2019, through a provisional agreement with ResMed NZ Limited.
Closes: 4pm Monday, 15 July 2019.
OIA Response: Drug shortages
Request dated 29 January 2019 for information relating to medicine stock shortages.
OIA Response: Pembrolizumab and nivolumab data
Request dated 29 January 2019 for information relating to Special Authorities for pembrolizumab and nivolumab for November and December 2018.
OIA Response: Waitangi Tribunal research report
Request dated 20 December 2018 for information relating to health services and outcomes for Maori.
Proposal for changes to funded male latex condoms - UPDATED DATES
We are proposing to increase the range of funded male latex condoms from 1 October 2019 and change the funded brands following a transition period. There would be a wider range of funded male latex condoms available, including flavoured condoms in a range of sizes and thin and coloured condoms becoming funded for the first time.
Closes: 4pm Wednesday, 3 July 2019.
Proposal to list products in the surgical suction, chest and wound drainage; and obstetrics and gynaecology categories supplied by W M Bamford
PHARMAC is seeking feedback on a proposal to list a range of obstetrics and gynaecology products and surgical suction, chest and wound drainage products in Part III of Section H of the Pharmaceutical Schedule from 1 September 2019 through a provisional agreement with W M Bamford and Co Limited.
Closes: 4pm Monday, 8 July 2019.
OIA Response: Pembrolizumab criteria
Request dated 10 April 2019 for information relating to pembrolizumab criteria.
OIA Response: Lamotrigine correspondence
Request dated Friday 12 April 2019 for information relating to the decision to move to one funded brand of lamotrigine.
OIA Response: Meningococcal W and Scout Jamboree
Thank you for your request dated 12 April 2019 under the Official Information Act 1982 (OIA) for information relating to Meningococcal W and the Scout Jamboree in Northland.
OIA Response: Insulin needles and syringes data
Request dated 1 May 2019 for information relating to insulin needles and syringes.
OIA Response: Pertuzumab renewals data
Request dated 29 April 2019 for number of Special Authority renewals for pertuzumab for 2017, 2018, and 2019.
OIA Response: Venlafaxine brand change roll out plan
Response to your request under the Official Information Act 1982 (OIA) for information relating to venlafaxine brand change roll out plan.
OIA Response: Parental leave policies
Request dated 11 April 2019 for information relating to parental leave policies at PHARMAC.
OIA Response: Vaccine costs
Request dated 8 April 2019 for information relating to vaccine costs in New Zealand.
Proposal to list urology products supplied by CR Kennedy (NZ) Limited
PHARMAC is seeking feedback on a proposal to list a range of urology products in Part III of Section H of the Pharmaceutical Schedule from 1 August 2019, though a listing agreement with CR Kennedy (NZ) Limited.
Closes: 4pm Friday, 5 July 2019.